MAM
LLY icon

Mastrapasqua Asset Management’s Eli Lilly LLY Stock Holding History

Mastrapasqua Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$23.7M Sell
44,031
-200
-0.5% -$103K 2.77% 5
2023
Q2 		$20.7M Buy
44,231
+73
+0.2% +$30.6K 2.33% 7
2023
Q1 		$15.2M Buy
44,158
+946
+2% +$319K 1.86% 14
2022
Q4 		$15.8M Buy
43,212
+17,676
+69% +$6.27M 2.08% 9
2022
Q3 		$8.26M Buy
25,536
+2,685
+12% +$851K 1.19% 31
2022
Q2 		$7.41M Buy
22,851
+11,822
+107% +$3.55M 1.01% 36
2022
Q1 		$3.16M Sell
11,029
-1,880
-15% -$484K 0.35% 69
2021
Q4 		$3.57M Buy
12,909
+769
+6% +$195K 0.35% 70
2021
Q3 		$2.81M Sell
12,140
-1,418
-10% -$350K 0.31% 74
2021
Q2 		$3.11M Buy
13,558
+1,165
+9% +$234K 0.33% 74
2021
Q1 		$2.31M Buy
12,393
+1,375
+12% +$269K 0.27% 79
2020
Q4 		$1.86M Sell
11,018
-2,395
-18% -$358K 0.24% 83
2020
Q3 		$1.99M Buy
13,413
+2,310
+21% +$358K 0.28% 77
2020
Q2 		$1.82M Buy
11,103
+148
+1% +$22.7K 0.28% 78
2020
Q1 		$1.52M Buy
10,955
+2,005
+22% +$275K 0.29% 76
2019
Q4 		$1.18M Sell
8,950
-135
-1% -$15.6K 0.19% 93
2019
Q3 		$1.02M Sell
9,085
-100
-1% -$11.1K 0.19% 91
2019
Q2 		$1.02M Sell
9,185
-30
-0.3% -$3.53K 0.19% 93
2019
Q1 		$1.2M Sell
9,215
-5
-0.1% -$608 0.23% 93
2018
Q4 		$1.07M Sell
9,220
-170
-2% -$19K 0.24% 92
2018
Q3 		$1.01M Buy
9,390
+430
+5% +$43K 0.19% 93
2018
Q2 		$765K Sell
8,960
-185
-2% -$15.2K 0.15% 105
2018
Q1 		$708K Sell
9,145
-65
-0.7% -$5.23K 0.14% 115
2017
Q4 		$778K Buy
9,210
+110
+1% +$9.36K 0.16% 108
2017
Q3 		$778K Sell
9,100
-610
-6% -$50K 0.16% 106
2017
Q2 		$799K Buy
9,710
+500
+5% +$40.8K 0.17% 105
2017
Q1 		$775K Buy
9,210
+2,085
+29% +$167K 0.17% 105
2016
Q4 		$524K Sell
7,125
-275
-4% -$20.5K 0.13% 113
2016
Q3 		$594K Buy
7,400
+300
+4% +$24K 0.15% 101
2016
Q2 		$559K Buy
7,100
+35
+0.5% +$2.63K 0.14% 110
2016
Q1 		$509K Buy
7,065
+205
+3% +$15.5K 0.12% 108
2015
Q4 		$578K Sell
6,860
-325
-5% -$27K 0.14% 102
2015
Q3 		$601K Buy
7,185
+5
+0.1% +$422 0.16% 96
2015
Q2 		$599K Buy
+7,180
New +$547K 0.15% 98
2015
Q1 		– Sell
-6,755
Closed -$466K – 81
2014
Q4 		$466K Buy
+6,755
New +$456K 0.11% 109
2014
Q2 		$422K Buy
6,785
+55
+0.8% +$3.28K 0.1% 119
2014
Q1 		$396K Sell
6,730
-695
-9% -$38.8K 0.09% 121
2013
Q4 		$379K Buy
7,425
+120
+2% +$6.01K 0.09% 128
2013
Q3 		$368K Sell
7,305
-395
-5% -$20.7K 0.09% 130
2013
Q2 		$378K Buy
+7,700
New +$419K 0.1% 119

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mastrapasqua Asset Management's LLY Position: Q3 2023 in Review

Mastrapasqua Asset Management reduced its Eli Lilly (LLY) stake by 0.45% in Q3 2023, selling an estimated $103K and leaving 44,031 shares worth $23.7M. The position accounts for 2.77% of the portfolio, ranked #5.

Mastrapasqua Asset Management first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Mastrapasqua Asset Management held 44,031 shares of Eli Lilly worth $23.7M as of Q3 2023.
  • Mastrapasqua Asset Management sold 200 Eli Lilly shares in Q3 2023, an estimated $103K.
  • Eli Lilly made up 2.77% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #5 holding.
  • Mastrapasqua Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.